Cingulate, Inc. (CING)
5.34
+0.15
(+2.89%)
USD |
NASDAQ |
Sep 09, 10:56
Cingulate Price to Book Value : 3.162 for Sept. 9, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 3.073 |
| September 04, 2026 | 3.020 |
| September 03, 2026 | 3.091 |
| September 02, 2026 | 3.049 |
| September 01, 2026 | 3.026 |
| August 31, 2026 | 3.061 |
| August 28, 2026 | 3.153 |
| August 27, 2026 | 3.221 |
| August 26, 2026 | 3.197 |
| August 25, 2026 | 3.476 |
| August 24, 2026 | 3.363 |
| August 21, 2026 | 3.286 |
| August 20, 2026 | 3.156 |
| August 19, 2026 | 3.120 |
| August 18, 2026 | 3.079 |
| August 17, 2026 | 3.085 |
| August 14, 2026 | 3.014 |
| August 13, 2026 | 2.955 |
| August 12, 2026 | 3.085 |
| August 11, 2026 | 3.079 |
| August 10, 2026 | 3.108 |
| August 07, 2026 | 3.162 |
| August 06, 2026 | 2.990 |
| August 05, 2026 | 2.925 |
| August 04, 2026 | 2.901 |
| Date | Value |
|---|---|
| August 03, 2026 | 2.860 |
| July 31, 2026 | 2.836 |
| July 30, 2026 | 2.818 |
| July 29, 2026 | 2.679 |
| July 28, 2026 | 2.682 |
| July 27, 2026 | 2.676 |
| July 24, 2026 | 2.747 |
| July 23, 2026 | 2.866 |
| July 22, 2026 | 2.866 |
| July 21, 2026 | 2.827 |
| July 20, 2026 | 2.70 |
| July 17, 2026 | 2.688 |
| July 16, 2026 | 2.623 |
| July 15, 2026 | 2.718 |
| July 14, 2026 | 2.789 |
| July 13, 2026 | 2.771 |
| July 10, 2026 | 2.907 |
| July 09, 2026 | 2.931 |
| July 08, 2026 | 2.866 |
| July 07, 2026 | 3.014 |
| July 06, 2026 | 3.138 |
| July 02, 2026 | 3.186 |
| July 01, 2026 | 3.488 |
| June 30, 2026 | 3.239 |
| June 29, 2026 | 3.358 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.701 |
| Corcept Therapeutics, Inc. | 17.85 |
| Veru, Inc. | 1.532 |
| Johnson & Johnson | 7.627 |
| Eli Lilly & Co. | 31.33 |
Price to Book Value Related Metrics
| Price | 5.34 |
| Earnings Yield | -67.71% |
| Market Cap | 74.20M |